TP53 and glioma: Distant regulatory mechanisms or promoter functions have been suggested for some of variants, such as the variants mapping to 8p24, MYC, TERT, PHDLB1, and TP53. Further research into the molecular mechanisms behind the observed associations with increased glioma risk is necessary to improve the understanding of glioma etiopathogenesis.